Ludwig, H., & Goldschmidt, H. (2018). Prevention and management of adverse events of novel agents in multiple myeloma: A consensus of the European Myeloma Network. Leukemia, 32(7), . https://doi.org/10.1038/s41375-018-0040-1
Chicago Style (17th ed.) CitationLudwig, Heinz, and Hartmut Goldschmidt. "Prevention and Management of Adverse Events of Novel Agents in Multiple Myeloma: A Consensus of the European Myeloma Network." Leukemia 32, no. 7 (2018). https://doi.org/10.1038/s41375-018-0040-1.
MLA (9th ed.) CitationLudwig, Heinz, and Hartmut Goldschmidt. "Prevention and Management of Adverse Events of Novel Agents in Multiple Myeloma: A Consensus of the European Myeloma Network." Leukemia, vol. 32, no. 7, 2018, https://doi.org/10.1038/s41375-018-0040-1.
Warning: These citations may not always be 100% accurate.